Ira Shafran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ira Shafran has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Pena Rossi
Merck Serono S.A., Geneva, Switzerland
1 shared publication F.A.X. Kl-Zaatari
1 shared publication- Hans Graffner
Merck Serono S.A. – Geneva, 15bis, Chemin des Mines, CH-1211 Geneva 20, Switzerland
1 shared publication J. Sandoval
1 shared publication- John O. Hunter
Addenbrooke's NHS Trust, Cambridge, UK
1 shared publication L. Kugler
1 shared publication
Latest Publications
- Open Access
- 20 March 2009
- Published by Springer Nature in BMC Gastroenterology
- Vol. 9 (1) , 22
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study
Crohn's disease (CD) and multiple sclerosis (MS) share common pathogenic processes. Interferon (IFN) beta-1a is effective and generally well tolerated in patients with MS and has been shown to down-regulate the expression of interleukin-12, a cytokine that is thought to be involved in mucosal degeneration in CD. IFN beta-1a therefore offers promise as a treatment for CD.
- 20 March 2009
- Published by Springer Nature in BMC Gastroenterology
- Vol. 9 (1) , 22
Open AccessInterferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study
Crohn's disease (CD) and multiple sclerosis (MS) share common pathogenic processes. Interferon (IFN) beta-1a is effective and generally well tolerated in patients with MS and has been shown to down-regulate the expression of interleukin-12, a cytokine that is thought to be involved in mucosal degeneration in CD. IFN beta-1a therefore offers promise as a treatment for CD.
- 1 January 2002
- Published by Elsevier in Digestive and Liver Disease
- Vol. 34 (1) , 22-28
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease
- 1 January 2002
- Published by Elsevier in Digestive and Liver Disease
- Vol. 34 (1) , 22-28
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease